
Milton Nelson Jr.
Examiner (ID: 8060, Phone: (571)272-6861 , Office: P/3636 )
| Most Active Art Unit | 3636 |
| Art Unit(s) | 3624, 3636, 3507, 2899 |
| Total Applications | 4348 |
| Issued Applications | 3635 |
| Pending Applications | 235 |
| Abandoned Applications | 521 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16326812
[patent_doc_number] => 20200297777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => METHODS OF TRANSDIFFERENTIATION AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/836967
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16836967
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/836967 | Methods of transdifferentiation and methods of use thereof | Mar 31, 2020 | Issued |
Array
(
[id] => 16345126
[patent_doc_number] => 20200309776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => HLA G-MODIFIED CELLS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/832321
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16832321
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/832321 | HLA G-MODIFIED CELLS AND METHODS | Mar 26, 2020 | Abandoned |
Array
(
[id] => 17748303
[patent_doc_number] => 20220226506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => EXPRESSION CONSTRUCTS FOR THE GENETIC MODIFICATION OF CELLS
[patent_app_type] => utility
[patent_app_number] => 17/439921
[patent_app_country] => US
[patent_app_date] => 2020-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439921
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439921 | EXPRESSION CONSTRUCTS FOR THE GENETIC MODIFICATION OF CELLS | Mar 16, 2020 | Pending |
Array
(
[id] => 17664111
[patent_doc_number] => 11357787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Method for selecting cells, method for producing nucleic acid, method for producing recombinant cells, method for producing target substance, method for producing pharmaceutical composition, and reagent
[patent_app_type] => utility
[patent_app_number] => 17/431268
[patent_app_country] => US
[patent_app_date] => 2020-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 13877
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431268
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431268 | Method for selecting cells, method for producing nucleic acid, method for producing recombinant cells, method for producing target substance, method for producing pharmaceutical composition, and reagent | Feb 16, 2020 | Issued |
Array
(
[id] => 16013453
[patent_doc_number] => 20200181569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => EXPANDABLE CELL POPULATIONS FROM BRAIN BIOPSIES OF LIVING SUBJECTS
[patent_app_type] => utility
[patent_app_number] => 16/788037
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788037
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/788037 | EXPANDABLE CELL POPULATIONS FROM BRAIN BIOPSIES OF LIVING SUBJECTS | Feb 10, 2020 | Abandoned |
Array
(
[id] => 16188561
[patent_doc_number] => 20200229410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/782708
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782708
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/782708 | Genetically modified non-human animals and methods of use thereof | Feb 4, 2020 | Issued |
Array
(
[id] => 16590580
[patent_doc_number] => 10899830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Methods and compositions for delivering MRNA coded antibodies
[patent_app_type] => utility
[patent_app_number] => 16/752327
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17916
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/752327 | Methods and compositions for delivering MRNA coded antibodies | Jan 23, 2020 | Issued |
Array
(
[id] => 18301092
[patent_doc_number] => 11622978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Immune cells defective for SUV39H1
[patent_app_type] => utility
[patent_app_number] => 16/747198
[patent_app_country] => US
[patent_app_date] => 2020-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18708
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16747198
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/747198 | Immune cells defective for SUV39H1 | Jan 19, 2020 | Issued |
Array
(
[id] => 15899205
[patent_doc_number] => 20200149121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => METHOD FOR UTILIZING ENGINEERED DENDRITIC CELLS TO INDUCE GUT-HOMING REGULATORY T CELLS AND TREAT GUT INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/744296
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744296
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744296 | Method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells and treat gut inflammation | Jan 15, 2020 | Issued |
Array
(
[id] => 17312862
[patent_doc_number] => 20210401910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/733453
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16733453
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/733453 | EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING THE SAME | Jan 2, 2020 | Abandoned |
Array
(
[id] => 16748866
[patent_doc_number] => 20210100875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => RESTORATION OF VISUAL RESPONSES BY IN VIVO DELIVERY OF RHODOPSIN NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/700201
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700201
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/700201 | Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids | Dec 1, 2019 | Issued |
Array
(
[id] => 20127940
[patent_doc_number] => 12370240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Methods and compositions for treating osteoarthritis
[patent_app_type] => utility
[patent_app_number] => 17/295588
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18887
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295588
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295588 | Methods and compositions for treating osteoarthritis | Nov 25, 2019 | Issued |
Array
(
[id] => 17412731
[patent_doc_number] => 20220047635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/309209
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309209
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309209 | METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY | Nov 21, 2019 | Pending |
Array
(
[id] => 18027967
[patent_doc_number] => 11511129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Photosensitive cardiac rhythm modulation systems
[patent_app_type] => utility
[patent_app_number] => 16/689178
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 13090
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689178
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/689178 | Photosensitive cardiac rhythm modulation systems | Nov 19, 2019 | Issued |
Array
(
[id] => 15589707
[patent_doc_number] => 20200071388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => Immunoglobulin Variable Region Libraries
[patent_app_type] => utility
[patent_app_number] => 16/688666
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8718
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16688666
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/688666 | Immunoglobulin Variable Region Libraries | Nov 18, 2019 | Abandoned |
Array
(
[id] => 16053241
[patent_doc_number] => 20200188475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => REAGENTS FOR INDUCING AN IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 16/683882
[patent_app_country] => US
[patent_app_date] => 2019-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16683882
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/683882 | REAGENTS FOR INDUCING AN IMMUNE RESPONSE | Nov 13, 2019 | Abandoned |
Array
(
[id] => 17503510
[patent_doc_number] => 20220096612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHODS FOR INDUCING IMMUNE TOLERANCE
[patent_app_type] => utility
[patent_app_number] => 17/292923
[patent_app_country] => US
[patent_app_date] => 2019-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292923
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292923 | METHODS FOR INDUCING IMMUNE TOLERANCE | Nov 11, 2019 | Pending |
Array
(
[id] => 15895237
[patent_doc_number] => 20200147137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/679127
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -89
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16679127
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/679127 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | Nov 7, 2019 | Abandoned |
Array
(
[id] => 17533907
[patent_doc_number] => 20220112516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => GENE THERAPY EMPLOYING GENOME EDITING WITH SINGLE AAV VECTOR
[patent_app_type] => utility
[patent_app_number] => 17/292343
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292343
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292343 | GENE THERAPY EMPLOYING GENOME EDITING WITH SINGLE AAV VECTOR | Nov 7, 2019 | Abandoned |
Array
(
[id] => 17314901
[patent_doc_number] => 20210403949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => VECTOR SYSTEM FOR EXPRESSING REGULATORY RNA
[patent_app_type] => utility
[patent_app_number] => 17/289653
[patent_app_country] => US
[patent_app_date] => 2019-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289653 | Vector system for expressing regulatory RNA | Nov 4, 2019 | Issued |